A NEW landmark study into the effects of cannabidiol (CBD) on psychosis is scheduled to be launched ‘later this year’.
CANADIAN CANNABIS PRICES Canadian wholesale cannabis prices are off more than 40% in 2022 Canadian cannabis wholesale prices tumbled more
WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future. However, one
Akanda Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not
VIRGINIA CANNABIS Virginia House panel kills GOP-led push to legalize retail cannabis sales Benzinga reports that Virginia lawmakers struck down
PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals (“GW”;
INSPIRE TECHNOLOGY Three firms steer e-cig and cannabis firm’s $42m IPO filing Law 360 reports that the e-cigarette and cannabis
Oxford Cannabinoid Technologies THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the
SHARE-PRICE WARNING The Nasdaq stock exchange warns Organigram Holdings about their share price The Nasdaq stock exchange has warned Organigram
LAST week a flurry of positive announcements from across the UK’s medical cannabis industry were unveiled in signs the industry
© 2023 Prohibition Holdings Ltd. All Rights Reserved.